McKinsey & Company research indicates that 70% of C-suite technology executives at large enterprises are already exploring and investing in digital twins. Interest in digital twins, combined with rapidly advancing supportive technologies, is spurring market estimates for digital-twin investments of more than $48 billion by 2026.

Patient Digital Twins are now reshaping healthcare and pharma through their applications in personalized precision medicine, patient diagnoses, as well as drug discovery, development & commercialization. These solutions prioritize privacy and security, fostering a future where integrated data leads to more patient-centered approaches. Join the healthcare revolution! Talk with Clinakos Inc. to see how we can transform your business with patient digital twins. 💙🚀

https://lnkd.in/gm7nTYTm